Apparent Diffusion Coefficients at Diffusion-weighted MR Imaging: Potential Predictors of Survival in Patients with Hepatocellular Carcinoma Treated with Chemoembolization
Xiao-Dan Ye,Wen Tao Li,Yuxin Zheng
DOI: https://doi.org/10.1148/radiol.14141025
IF: 19.7
2014-01-01
Radiology
Abstract:HomeRadiologyVol. 272, No. 3 PreviousNext CommunicationsLetters to the EditorApparent Diffusion Coefficients at Diffusion-weighted MR Imaging: Potential Predictors of Survival in Patients with Hepatocellular Carcinoma Treated with ChemoembolizationXiao-Dan Ye*, Wen-Tao Li†, Zheng Yuan†,‡ Xiao-Dan Ye*, Wen-Tao Li†, Zheng Yuan†,‡ Author AffiliationsDepartment of Radiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China*Department of Radiology, Shanghai Cancer Hospital, Fudan University, 270 Dong An Rd, Shanghai 200032, China†Department of Radiology, Shanghai No. 85 Hospital, Shanghai, China‡e-mail: [email protected]Xiao-Dan Ye*Wen-Tao Li†Zheng Yuan†,‡ Published Online:Aug 25 2014https://doi.org/10.1148/radiol.14141025MoreSectionsFull textPDF ToolsAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookXLinked In References1. Vandecaveye V, Michielsen K, De Keyzer F, et al. Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome. Radiology 2014;270(3):747–757. Link, Google Scholar2. Yuan Z, Li WT, Peng WJ. Pre-treatment apparent diffusion coefficient is imaging biomarker for prediction of response to chemoembolization in hepatocellular carcinoma. Eur J Radiol 2013;82(12):e901–e902. Crossref, Medline, Google Scholar3. Yuan Z, Ye XD, Dong S, et al. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma. Eur J Radiol 2010;75(1):e9–e14. Crossref, Medline, Google Scholar4. Kubota K1, Yamanishi T, Itoh S, et al. Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma. Oncol Rep 2010;24(3):727–732. Medline, Google Scholar5. Mannelli L, Kim S, Hajdu CH, et al. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to transarterial chemoembolization—preliminary experience. Eur J Radiol 2013;82:577–582. Crossref, Medline, Google Scholar6. Dong S, Ye XD, Yuan Z, et al. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization. Eur J Radiol 2012;81(3):472–477. Crossref, Medline, Google Scholar7. Song MJ, Chun HJ, Song do S, et al. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol 2012;57(6):1244–1250. Crossref, Medline, Google Scholar8. Sacco R, Bargellini I, Bertini M, et al. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2011;22(11):1545–1552. Crossref, Medline, Google ScholarArticle HistoryPublished online: Aug 25 2014Published in print: Sept 2014 FiguresReferencesRelatedDetailsCited ByRadiological biomarkers for assessing response to locoregional therapies in hepatocellular carcinoma: From morphological to functional imagingXiao-DanYe, ZuguoYuan, JianZhang, ZhengYuan3 February 2017 | Oncology Reports, Vol. 37, No. 3Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional TreatmentZhengYuan, JianZhang, HuanYang, Xiao-DanYe, Li-ChaoXu, Wen-TaoLi2016Jan1 | Journal of Vascular and Interventional Radiology, Vol. 27, No. 1Recommended Articles Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular CarcinomaRadiology2016Volume: 280Issue: 2pp. 630-639Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular CarcinomaRadiology2017Volume: 285Issue: 1pp. 311-318Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?Radiology2018Volume: 289Issue: 3pp. 843-853Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Radiology2016Volume: 283Issue: 3pp. 883-894Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical TranslationRadiology: Imaging Cancer2023Volume: 5Issue: 3See More RSNA Education Exhibits Imaging Assessment Of Treatment Response In Hepatocarcinoma: Is That Tumor Viable Or Not?Digital Posters2021Treatment Response Assessment After Radiation Therapy For Hepatocellular Carcinoma (HCC): Diagnostic ChallengesDigital Posters2021Imaging Diagnosis of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapy and ImmunotherapyDigital Posters2022 RSNA Case Collection LI-RADS 5RSNA Case Collection2022Hepatic AdenomatosisRSNA Case Collection2021Radioembolization of Liver Metastasis RSNA Case Collection2020 Vol. 272, No. 3 Metrics Altmetric Score PDF download